179 related articles for article (PubMed ID: 35839982)
1. Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway.
Yuan Z; Liu C; Sun Y; Li Y; Wu H; Ma S; Shang J; Zhan Y; Yin P; Gao F
Int J Pharm; 2022 Aug; 624():122018. PubMed ID: 35839982
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.
Yuan Z; Fan G; Wu H; Liu C; Zhan Y; Qiu Y; Shou C; Gao F; Zhang J; Yin P; Xu K
Mol Ther; 2021 Oct; 29(10):2931-2948. PubMed ID: 34023507
[TBL] [Abstract][Full Text] [Related]
3. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
Wang Y; Huo J; Li S; Huang R; Fan D; Cheng H; Wan B; Du Y; He H; Zhang G
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10092-10101. PubMed ID: 35170301
[TBL] [Abstract][Full Text] [Related]
4. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
[TBL] [Abstract][Full Text] [Related]
7. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
[TBL] [Abstract][Full Text] [Related]
8. Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Tao Y; Liu Y; Dong Z; Chen X; Wang Y; Li T; Li J; Zang S; He X; Chen D; Zhao Z; Li M
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44039-44053. PubMed ID: 36153957
[TBL] [Abstract][Full Text] [Related]
9. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
10. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
[TBL] [Abstract][Full Text] [Related]
11. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells.
Rodríguez ME; Catrinacio C; Ropolo A; Rivarola VA; Vaccaro MI
Photochem Photobiol Sci; 2017 Nov; 16(11):1631-1642. PubMed ID: 28936522
[TBL] [Abstract][Full Text] [Related]
12. Self-amplified activatable nanophotosensitizers for HIF-1α inhibition-enhanced photodynamic therapy.
Guo Z; Wang N; He X; Shen J; Yang X; Xie C; Fan Q; Zhou W
Nanoscale; 2024 Feb; 16(8):4239-4248. PubMed ID: 38348473
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab-Ag
Hashemkhani M; Demirci G; Bayir A; Muti A; Sennaroglu A; Mohammad Hadi L; Yaghini E; Loizidou M; MacRobert AJ; Yagci Acar H
Nanoscale; 2021 Sep; 13(35):14879-14899. PubMed ID: 34533177
[TBL] [Abstract][Full Text] [Related]
14. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-Self-Supplying and HIF-1α-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy.
Liu P; Xie X; Shi X; Peng Y; Ding J; Zhou W
ACS Appl Mater Interfaces; 2019 Dec; 11(51):48261-48270. PubMed ID: 31763809
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
[TBL] [Abstract][Full Text] [Related]
19. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
